Advisors Capital Management LLC Sells 21,310 Shares of Relx Plc $RELX

Advisors Capital Management LLC lowered its stake in Relx Plc (NYSE:RELX) by 14.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 125,381 shares of the technology company’s stock after selling 21,310 shares during the quarter. Advisors Capital Management LLC’s holdings in Relx were worth $6,813,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Fiera Capital Corp increased its holdings in shares of Relx by 15.3% in the second quarter. Fiera Capital Corp now owns 12,008 shares of the technology company’s stock worth $653,000 after purchasing an additional 1,597 shares during the last quarter. Bailard Inc. grew its holdings in Relx by 117.0% during the 2nd quarter. Bailard Inc. now owns 25,370 shares of the technology company’s stock valued at $1,379,000 after buying an additional 13,677 shares in the last quarter. ABC Arbitrage SA increased its stake in Relx by 188.9% in the 2nd quarter. ABC Arbitrage SA now owns 560,958 shares of the technology company’s stock worth $30,482,000 after acquiring an additional 366,761 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Relx by 5.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 50,495 shares of the technology company’s stock worth $2,744,000 after acquiring an additional 2,782 shares in the last quarter. Finally, SBI Securities Co. Ltd. boosted its position in shares of Relx by 407.2% during the 2nd quarter. SBI Securities Co. Ltd. now owns 1,765 shares of the technology company’s stock valued at $96,000 after acquiring an additional 1,417 shares during the last quarter. Hedge funds and other institutional investors own 15.02% of the company’s stock.

Analysts Set New Price Targets

RELX has been the topic of several research reports. Kepler Capital Markets upgraded shares of Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Morgan Stanley reissued an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. Wall Street Zen cut shares of Relx from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Barclays reaffirmed an “overweight” rating on shares of Relx in a report on Tuesday, October 7th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Relx in a research note on Thursday. One equities research analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the company. According to MarketBeat.com, Relx currently has a consensus rating of “Buy”.

Relx Price Performance

Shares of RELX stock opened at $41.29 on Friday. The stock has a 50 day moving average price of $45.49 and a 200 day moving average price of $49.79. Relx Plc has a 52-week low of $40.77 and a 52-week high of $56.33. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.